Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 16, 2013

Alcobra, Alnylam, BioLineRx, Cubist, Gilead, La Jolla, NeoStem, PharmAthene, Recipharm, Shield

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II
Alcobra posts adult ADHD results . . . read more

Alnylam begins subcutaneous ATTR treatment trial . . . read more

Initial results in for BioLineRx AML trial . . . read more

La Jolla begins CKD trial . . . read more

NeoStem completes enrollment in CV trial . . . read more

Phase III
Cubist posts topline results from cIAI trial . . . read more

Filings
Gilead Complera one-tab HIV regimen approved for new patient group . . . read more

PharmAthene trial placed on clinical hold . . . read more

Recipharm unit files infectious app . . . read more

Shield cleared for CKD trial . . . read more

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters